Nuvation Bio Inc.
Total Trades
31
Buys
13
Sells
10
Largest Trade
$1M+
Insiders
15
Institutional Funds
169
Inst. Value
$1M+
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Liu Dongfang | CHIEF MEDICAL OFFI… | EXERCISE | $100K–$500K | 150K | $2.93 | Dec 3, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | SELL | $1M+ | 150K | $7.82 | Dec 3, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | EXERCISE | $50K–$100K | 20K | $3.61 | Nov 26, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 20K | $7.75 | Nov 26, 2025 |
| Hattersley Gary | CHIEF SCIENTIFIC O… | EXERCISE | $500K+ | 369K | $1.90 | Nov 24, 2025 |
| Hattersley Gary | CHIEF SCIENTIFIC O… | SELL | $1M+ | 369K | $7.23 | Nov 24, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 20K | $7.00 | Nov 24, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | EXERCISE | $15K–$50K | 20K | $1.87 | Nov 24, 2025 |
| Hanley David C. | CHIEF TECHNICAL OP… | SELL | $1M+ | 200K | $7.14 | Nov 21, 2025 |
| Hanley David C. | CHIEF TECHNICAL OP… | EXERCISE | $100K–$500K | 200K | $1.87 | Nov 21, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 30K | $4.93 | Nov 19, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | EXERCISE | $50K–$100K | 30K | $1.87 | Nov 19, 2025 |
| Hattersley Gary | CHIEF SCIENTIFIC O… | SELL | $500K+ | 100K | $5.02 | Oct 29, 2025 |
| Hattersley Gary | CHIEF SCIENTIFIC O… | EXERCISE | $100K–$500K | 100K | $1.74 | Oct 29, 2025 |
| Markel Stacy | CHIEF PEOPLE OFFICER | BUY | $15K–$50K | 10K | $1.71 | Jun 18, 2025 |
| Sauvage Philippe | CFO | BUY | $1K–$15K | 7K | $1.81 | Jun 18, 2025 |
| Sjogren Colleen | Chief Commercial O… | BUY | $50K–$100K | 50K | $1.81 | Jun 18, 2025 |
| Wentworth Kerry | CHIEF REGULATORY O… | BUY | $50K–$100K | 50K | $1.79 | Jun 18, 2025 |
| Hung David | PRESIDENT AND CEO | BUY | $500K+ | 500K | $1.79 | Jun 18, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 20K | $2.50 | May 6, 2025 |
| Liu Dongfang | CHIEF MEDICAL OFFI… | EXERCISE | $15K–$50K | 20K | $1.94 | May 6, 2025 |
| Hung David | PRESIDENT AND CEO | BUY | $500K+ | 500K | $1.64 | Apr 9, 2025 |
| Mashal Robert | Director | BUY | $100K–$500K | 100K | $1.67 | Apr 3, 2025 |
| Wang Junyuan Jerry | CEO | SELL | $100K–$500K | 56K | $2.89 | Nov 13, 2024 |
| Mashal Robert | Director | BUY | $100K–$500K | 100K | $2.20 | Oct 10, 2024 |
| Cui Xiangmin | Director | BUY | $500K+ | 278K | $2.97 | Jun 26, 2024 |
| Cui Xiangmin | Director | BUY | $1M+ | 500K | $2.98 | Jun 25, 2024 |
| BLICKENSTAFF KIM D | Director | BUY | $500K+ | 172K | $2.90 | Jun 13, 2024 |
| NODELMAN OLEG | Director | BUY | $1M+ | 5.3M | $1.26 | Sep 22, 2023 |
| FALBERG KATHRYN E | Director | BUY | $100K–$500K | 250K | $1.94 | Dec 5, 2022 |
| Omega Fund V, L.P. | 10% Owner | SELL | $1M+ | 2.5M | $5.60 | Apr 7, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 169 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Decheng Capital LLC | 26.0M | $1M+ | SH |
| Laurion Capital Management LP | 7.9M | $1M+ | SH |
| STATE STREET CORP | 5.9M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 4.9M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 3.9M | $1M+ | SH |
| ABRAMS CAPITAL MANAGEMENT, L.P. | 3.8M | $1M+ | SH |
| Redmile Group, LLC | 3.2M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 2.1M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.0M | $1M+ | SH |
| Capricorn Fund Managers Ltd | 1.6M | $1M+ | SH |
| SymBiosis Capital Partners, LLC | 1.3M | $1M+ | SH |
| NewEdge Advisors, LLC | 952K | $1M+ | SH |
| TANAKA CAPITAL MANAGEMENT INC | 842K | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 820K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 702K | $1M+ | SH |
| Neo Ivy Capital Management | 588K | $1M+ | SH |
| CAXTON ASSOCIATES LLP | 585K | $1M+ | SH |
| BlackRock, Inc. | 571K | $1M+ | SH |
| Palo Alto Investors LP | 538K | $1M+ | SH |
| JPMORGAN CHASE & CO | 466K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Jul 17, 2025
6.4%
21.7M shares
SC 13G/A · May 12, 2025
15.0%
50.6M shares
SC 13G/A · Apr 28, 2025
4.9%
16.4M shares
SC 13G/A · Feb 12, 2025
13.5%
45.3M shares
SC 13G/A · Dec 6, 2024
11.9%
40.0M shares
SC 13G/A · Nov 12, 2024
8.8%
29.2M shares
SC 13D/A · Oct 18, 2024
3.9%
13.1M shares
Decheng Capital China Life Sciences USD Fund III, L.P.
SC 13D · Sep 10, 2024
0.4%
1.3M shares
SC 13D/A · Mar 27, 2024
6.1B shares
SC 13G · Jan 29, 2024
5.9%
12.9M shares
SC 13G/A · Feb 14, 2023
3.8%
8.2M shares
SC 13D/A · Feb 13, 2023
6.9%
15.1M shares
SC 13G · Feb 13, 2023
5.0%
11.0M shares
SC 13G · Jun 23, 2022
5.3%
11.5M shares
SC 13G/A · Feb 11, 2022
0.1%
215K shares